Auckland, New Zealand – October 30, 2025 – (SeaPRwire) – At the inaugural European Union – New Zealand Business Summit, Decent Cybersecurity represented Europe’s growing strength in digital and defence technologies. The company’s Founder and CEO, Matej Michalko, joined industry leaders to discuss innovation partnerships, cybersecurity resilience, and post-quantum readiness across trans-Pacific markets. The event gathered over 400 participants from business, technology, and research communities, underscoring a shared commitment to building secure and sustainable digital infrastructure between Europe and New Zealand. Hosted by Hon Todd McClay, New Zealand’s Minister for Trade & Investment, in partnership with Team Europe (the Ambassadors of the EU and its Member States), the Summit celebrated the strong growth of trans-Pacific cooperation. Since the EU–NZ Free Trade Agreement entered into force in 2024, two-way trade has already risen by NZ $2 billion, reaching NZ $21.6 billion in 2025. The event was officially opened by Prime Minister Christopher Luxon, who described the EU as “an innovation partner” and emphasised the shared values and strategic alignment between Europe and New Zealand in advancing trade, defence, and technology. A Platform for Global Partnerships and Digital Innovation Commissioner Šefčovič, a native of Slovakia, delivered a keynote address outlining Europe’s vision for resilient supply chains, strategic autonomy, and secure digital transition. Later in the day, the “Quickfire with Central and Eastern Europe” session showcased innovation leaders from across the region. Representing European Union and its member country Slovakia, Matej Michalko presented on the country’s growing role in post-quantum cybersecurity, AI for defence systems, and trusted blockchain infrastructure — areas where Decent Cybersecurity is establishing Europe-wide leadership. “It was an honour to represent European Union and Slovakia alongside Commissioner Šefčovič and to demonstrate how our country is contributing to Europe’s digital and defence sovereignty,” said Matej Michalko, CEO of Decent Cybersecurity. “The EU–New Zealand partnership opens new doors for innovation, technology exchange, and secure infrastructure development that transcend continents.” Shared Vision for Innovation and Security The Summit agenda featured strategic panels on clean tech, AI, bioeconomy, and aerospace & defence, with global leaders from Airbus, Rocket Lab, OHB, and Maersk. It culminated with a joint address by Commissioner Šefčovič and Minister McClay, setting out a shared vision for deeper economic and technological integration between Europe and New Zealand — an effort strongly endorsed by Prime Minister Luxon in his opening remarks. For Decent Cybersecurity, participation in this summit reinforces its mission to connect European post-quantum, blockchain and AI-driven innovation with global partners in the Asia-Pacific region — bridging defence, technology, and critical-infrastructure ecosystems. About Decent Cybersecurity Decent Cybersecurity s. r. o. is a European deep-tech company developing post-quantum and blockchain-based cybersecurity solutions for defence and critical infrastructure. Certified by TÜV SÜD (ISO 9001 and ISO 27001) and holding NATO, EU, and national SECRET-level security clearances, the company is a member of European Defence Fund (EDF) projects and a founding member of the Critical Infrastructure Association of Slovak Republic (Asociácia kritickej infraštruktúry SR, AKI SR). Media contact Brand: Decent Cybersecurity Contact: Media team Email: business@decentcybersecurity.eu Website: https://decentcybersecurity.eu
MHI Thermal Systems Launches Two New Models of Air-to-Water Heat Pumps Using Natural Refrigerant R290 for European Market
Hydrolution EZY SeriesTOKYO, October 30, 2025 - (JCN Newswire via SeaPRwire.com) - Mitsubishi Heavy Industries Thermal Systems, Ltd. (MHI Thermal Systems), a part of Mitsubishi Heavy Industries (MHI) Group, has added two new models to its "Hydrolution EZY" series of air-to-water (ATW) heat pumps for the European market that utilize R290 (propane). This is a natural refrigerant with low environmental impact and high energy efficiency. The new models have capacities of 6kW and 7.1kW and are scheduled for release this winter.ATW heat pumps extract heat from the air to supply cold and hot water for domestic water supply, heating, and cooling, replacing traditional fossil-fueled boilers.The models added to the lineup are monobloc types in which the water heat exchanger is housed in an outdoor unit, with only water piping required. Compared to split-type ATWs, which require the refrigerant pipe connections between an outdoor unit and an indoor unit, installation is easier.The R290 refrigerant used in these models has a very low environmental impact(*1) while retaining high energy efficiency. This is particularly important for the European market, as environmental regulations are tightened.Modifications that allow the use of R290 also enable the units to maintain a flow temperature of 75 in a wide range of environments, from an outside temperature of -25 to 43 meaning the unit can be relied upon for heating and domestic hot water applications even in the coldest regions. These latest models, in addition to high-temperature water-heating capabilities, are silent and easy to install, with only water piping and an electricity supply to the outdoor unit required. When operating at maximum capacity, the 6kW model has a sound pressure level, a measure of noise intensity, of just 34dB(A)(*2). The unit also has a quiet mode for reduced operating noise, providing flexibility to comply with noise regulations in densely populated residential areas.In addition, as a safety measure, the units are equipped with a refrigerant leak detection sensor. In the event of a leak, the unit will stop running, and a fan engaged to dissipate any escaped refrigerant.In order to better integrate into a range of installation environments across Europe, including residential areas, the models have been visually redesigned with an understated, modern appearance. The front of the now all-black unit is fitted with a fan guard accented with a silver vertical line and is designed to make it difficult to see the fan from an oblique direction.By promoting the transition from boiler combustion using fossil fuels that emit high concentrations of CO2, to ATW using electricity, Hydrolution EZY can make a significant contribution to carbon neutrality in European countries, and the achievement of MHI Group's MISSION NET ZERO.In October 2021, MHI Group announced its MISSION NET ZERO declaration to achieve carbon neutrality across the entire corporate group by 2040 by reducing CO2 emissions from its own plants and other production-related facilities, as well as through reductions in the CO2 emissions at customer facilities that use MHI Group products.Going forward, MHI Thermal Systems will continue to develop environmentally friendly technologies and products that take advantage of the breadth of the refrigeration and heating sector, and contribute to carbon neutrality in Europe and countries around the world.(*1) R290 has a global warming potential (GWP) of only 0.02. Global Warming Potential (GWP) is a coefficient expressing the greenhouse effect of a gas relative to carbon dioxide (CO2), which has a fixed GWP of 1.0. The lower the value, the lower the greenhouse effect and the better for the environment. The GWP value of "0.02" is adopted based on the IPCC Sixth Assessment Report.(*2) Value measured at three meters in front of the unit.About MHI GroupMitsubishi Heavy Industries (MHI) Group is one of the world’s leading industrial groups, spanning energy, smart infrastructure, industrial machinery, aerospace and defense. MHI Group combines cutting-edge technology with deep experience to deliver innovative, integrated solutions that help to realize a carbon neutral world, improve the quality of life and ensure a safer world. For more information, please visit www.mhi.com or follow our insights and stories on spectra.mhi.com Copyright 2025 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com
TIME បង្ហាញ TIME100 Climate List ឆ្នាំ២០២៥
(SeaPRwire) - ថ្ងៃនេះ TIME បានប្រកាសពីបញ្ជី TIME100 Climate ប្រចាំឆ្នាំលើកទីបី ដែលមានអ្នកដឹកនាំដែលមានឥទ្ធិពលបំផុត ១០០ រូប ដែលកំពុងជំរុញសកម្មភាពអាកាសធាតុសម្រាប់អាជីវកម្ម។ បញ្ជី TIME100 Climate ឆ្នាំ 2025 រួមមាន Pope Leo XIV, King Charles III, តារាសម្ដែង Samuel L. Jackson, ប្រធានាធិបតីប្រេស៊ីល Luiz Inácio Lula da Silva, ប្រធានធនាគារកណ្តាលអឺរ៉ុប European Central Bank Christine Lagarde, អភិបាលរដ្ឋកាលីហ្វ័រញ៉ា Gavin Newsom, អគ្គនាយកអង្គការពាណិជ្ជកម្មពិភពលោក World Trade Organization Ngozi Okonjo-Iweala, សហស្ថាបនិក និងនាយកប្រតិបត្តិនៃ Snap Inc. Evan Spiegel, តន្ត្រីករ និងសប្បុរសជន DJ Alok, ស្ថាបនិក និងប្រធាន Contemporary Amperex Technology Limited (CATL) Robin Zeng, ស្ថាបនិក និងនាយកជាន់ខ្ពស់នៃ Moms Clean Air Force Dominique Browning, និងច្រើនទៀត។ –ស្វែងយល់ពីបញ្ជី TIME100 Climate ពេញលេញសម្រាប់ឆ្នាំ 2025៖ –សូមមើលគម្របដែលបង្ហាញស្នាដៃសិល្បៈដោយវិចិត្រករ Michael Papadakis៖ ‘TIME100 IMPACT DINNER’ ដើម្បីទទួលស្គាល់អ្នកដឹកនាំដែលកំពុងបង្កើតសកម្មភាពអាកាសធាតុក្នុងអំឡុងពេល COP30 នៅ Rio៖ TIME នឹងរៀបចំកម្មវិធី TIME100 Impact Dinner: Leaders Creating Climate Action ដើម្បីលើកស្ទួយអ្នកដឹកនាំជាច្រើនរូប — រួមទាំងអ្នកដែលបានបង្ហាញខ្លួននៅក្នុងបញ្ជី TIME100 Climate ឆ្នាំ 2025 នៃអ្នកដឹកនាំផ្នែកអាកាសធាតុ — នៅថ្ងៃទី ៤ ខែវិច្ឆិកា ក្នុងអំឡុងពេល COP30 នៅទីក្រុង Rio ប្រទេសប្រេស៊ីល។ ព្រឹត្តិការណ៍នេះនឹងបង្ហាញពីការយល់ដឹងពីមេដឹកនាំអាជីវកម្ម អ្នកបង្កើតគោលនយោបាយ អ្នកតស៊ូមតិ និងច្រើនទៀត អំពីរបៀបដែលយើងអាចធ្វើការរួមគ្នាដើម្បីចាត់វិធានការប្រកបដោយអត្ថន័យ ដើម្បីថែរក្សាភពផែនដី និងធនធានរបស់យើង។ វាគ្មិនពិសេសរួមមាន៖ អ្នកស្រាវជ្រាវមហាសមុទ្រ Sylvia Earle, ប្រធានាធិបតីសូរីណាម Jennifer Geerlings-Simons, សកម្មជនអាកាសធាតុ Elizabeth Wathuti, អភិបាលក្រុង Rio de Janeiro Eduardo Paes និងច្រើនទៀត។ កម្មវិធី TIME100 Impact Dinner: Leaders Creating Climate Action ត្រូវបានឧបត្ថម្ភដោយនាឡិកាផ្លូវការ Rolex។ អត្ថបទនេះត្រូវបានផ្តល់ជូនដោយអ្នកផ្គត់ផ្គង់មាតិកាដែលទីបញ្ចូល។ SeaPRwire (https://www.seaprwire.com/) មិនមានការធានា ឬ បញ្ចេញកំណត់ណាមួយ។ ប្រភេទ: ព័ត៌មានប្រចាំថ្ងៃ, ព័ត៌មានសំខាន់ SeaPRwire ផ្តល់សេវាកម្មផ្សាយពាណិជ្ជកម្មសារព័ត៌មានសកលសម្រាប់ក្រុមហ៊ុន និងស្ថាប័ន ដែលមានការចូលដំណើរការនៅលើបណ្ដាញមេឌៀជាង 6,500 បណ្ដាញ ប័ណ្ណប្រតិភូ 86,000 និងអ្នកសារព័ត៌មានជាង 350 លាន។ SeaPRwire គាំទ្រការផ្សាយពាណិជ្ជកម្មជាសារព័ត៌មានជាភាសាអង់គ្លេស ជប៉ុន ហ្រ្វាំង គូរី ហ្វ្រេនច រ៉ុស អ៊ីនដូនេស៊ី ម៉ាឡេស៊ី វៀតណាម ចិន និងភាសាផ្សេងទៀត។
Decent Cybersecurity Highlights Slovakia’s Tech Leadership at the EU-NZ Business Summit
Auckland, New Zealand, Oct 30, 2025 - (ACN Newswire via SeaPRwire.com) - At the inaugural European Union – New Zealand Business Summit, Decent Cybersecurity represented Europe's growing strength in digital and defence technologies. The company's Founder and CEO, Matej Michalko, joined industry leaders to discuss innovation partnerships, cybersecurity resilience, and post-quantum readiness across trans-Pacific markets. The event gathered over 400 participants from business, technology, and research communities, underscoring a shared commitment to building secure and sustainable digital infrastructure between Europe and New Zealand.Hosted by Hon Todd McClay, New Zealand's Minister for Trade & Investment, in partnership with Team Europe (the Ambassadors of the EU and its Member States), the Summit celebrated the strong growth of trans-Pacific cooperation. Since the EU–NZ Free Trade Agreement entered into force in 2024, two-way trade has already risen by NZ $2 billion, reaching NZ $21.6 billion in 2025.The event was officially opened by Prime Minister Christopher Luxon, who described the EU as "an innovation partner" and emphasised the shared values and strategic alignment between Europe and New Zealand in advancing trade, defence, and technology.A Platform for Global Partnerships and Digital InnovationCommissioner Šefcovic, a native of Slovakia, delivered a keynote address outlining Europe's vision for resilient supply chains, strategic autonomy, and secure digital transition. Later in the day, the "Quickfire with Central and Eastern Europe" session showcased innovation leaders from across the region.Representing European Union and its member country Slovakia, Matej Michalko presented on the country's growing role in post-quantum cybersecurity, AI for defence systems, and trusted blockchain infrastructure — areas where Decent Cybersecurity is establishing Europe-wide leadership."It was an honour to represent European Union and Slovakia alongside Commissioner Šefcovic and to demonstrate how our country is contributing to Europe's digital and defence sovereignty," said Matej Michalko, CEO of Decent Cybersecurity. "The EU–New Zealand partnership opens new doors for innovation, technology exchange, and secure infrastructure development that transcend continents."Shared Vision for Innovation and SecurityThe Summit agenda featured strategic panels on clean tech, AI, bioeconomy, and aerospace & defence, with global leaders from Airbus, Rocket Lab, OHB, and Maersk. It culminated with a joint address by Commissioner Šefcovic and Minister McClay, setting out a shared vision for deeper economic and technological integration between Europe and New Zealand — an effort strongly endorsed by Prime Minister Luxon in his opening remarks.For Decent Cybersecurity, participation in this summit reinforces its mission to connect European post-quantum, blockchain and AI-driven innovation with global partners in the Asia-Pacific region — bridging defence, technology, and critical-infrastructure ecosystems.About Decent CybersecurityDecent Cybersecurity s. r. o. is a European deep-tech company developing post-quantum and blockchain-based cybersecurity solutions for defence and critical infrastructure. Certified by TÜV SÜD (ISO 9001 and ISO 27001) and holding NATO, EU, and national SECRET-level security clearances, the company is a member of European Defence Fund (EDF) projects and a founding member of the Critical Infrastructure Association of Slovak Republic (Asociácia kritickej infraštruktúry SR, AKI SR).Media contactBrand: Decent CybersecurityContact: Media teamWebsite: https://decentcybersecurity.eu Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
Hitachi Energy and Blackstone Energy Transition Partners enter strategic partnership to create leading energy service provider in North America
Zurich and New York, October 30, 2025 - (JCN Newswire via SeaPRwire.com) - Hitachi Energy, a wholly owned subsidiary of Hitachi, Ltd., today announced a strategic partnership with Blackstone Energy Transition Partners (“Blackstone”) to expand and strengthen its Service business, supporting customers in maintaining the reliability and safety of power infrastructure across North America. As part of the partnership, Hitachi Energy will acquire a stake in Shermco – a leading provider of comprehensive maintenance, repair, testing, commissioning, and design services in North America, recently acquired by private equity funds affiliated with Blackstone.The partnership brings together three industry leaders: Hitachi Energy, a global technology leader in electrification; Blackstone, the world’s largest alternative asset manager; and Shermco, a leading provider of electrical services in the U.S. and Canada. Together, they will seek to expand service capacity and capabilities to deliver comprehensive lifecycle support for critical energy infrastructure, from power generation and transmission to data centers and industrial electrification.“Investing in Shermco in partnership with Blackstone enables Hitachi Energy to accelerate our growth and expand service capabilities across North America. Our investment strengthens our service offering as we continue to scale, helping customers maintain and extend the life of existing assets while making the grid stronger, more resilient and fit for the future.”“We’re thrilled to welcome Hitachi Energy as a strategic partner alongside Blackstone,” said Phil Petrocelli, CEO of Shermco. “This investment is a testament to our commitment to serving our customers’ essential power needs and reputation for safety and excellence. With this additional support and resources, we look forward to expanding our footprint and capabilities to continue to accelerate our growth together.”“Hitachi Energy is a global leader across technology and energy with deep digital and operational expertise,” said David Foley, Global Head of Blackstone Energy Transition Partners. “We are excited to partner with Hitachi Energy to build on Shermco's success alongside Phil Petrocelli and its exceptional management team.” JP Munfa and Darius Sepassi, Senior Managing Directors at Blackstone, added, “Hitachi Energy’s investment in Shermco brings together a global technology leader in electrification with one of the leading North American providers of mission-critical maintenance, testing and design services for electrical equipment. We are thrilled to be partnering with Hitachi Energy and look forward to working together to accelerate Shermco’s next phase of growth in an era of rapid electrification and increasing demand.”Hitachi Energy’s $1 billion global investment in ServiceIn addition, Hitachi Energy is investing more than $1 billion USD globally to expand its Service footprint, launching new digital service solutions with HMAX Energy, and growing its workforce — including the development and certification of over 5,000 additional service experts worldwide. “By combining Hitachi Energy’s grid expertise and digital solutions with Shermco’s nationwide field service presence, we will set a new benchmark for electrical infrastructure services – creating the leading service partner in North America driving asset reliability and performance as well as digital innovation for utilities, industries and data centers alike,” said Wolf Mueller, Managing Director of Hitachi Energy’s Service Business.Strengthening Service capabilities for the electricity eraGlobally, power grids are aging, and the experienced workforce is retiring, creating significant challenges. As electrification accelerates across industries, transportation, and digital infrastructure, service is the backbone of grid modernization. Much of today’s grid infrastructure – more than 70 percent of U.S. transmission lines1 – is decades old, nearing or past its intended lifecycle, leading to higher outage risks, cyber vulnerabilities and costly emergency repairs. Service is critical to help data centers, utilities and industries maintain, upgrade, and optimize their infrastructure and increase the reliability, safety, flexibility and sustainability of energy systems.1DOE, What does it take to modernize the U.S.electric grid?(1) Founded in 1974 and headquartered in Texas, Shermco is one of the largest electrical testing organizations accredited by the InterNational Electrical Testing Association (“NETA”), providing comprehensive electrical system maintenance, repair, testing, commissioning and design services, with more than 600 NETA technicians and 200 engineers across 40 service centers in the U.S. and Canada. Shermco provides critical services for data centers, utilities and diversified commercial and industrial end-markets, partnering with customers to enhance the safety, reliability and efficiency of their critical electrical infrastructure, while minimizing downtime and outages.(2) HMAX Energy is Hitachi’s upcoming digitally enabled and AI-powered services offering related to the energy sector. As a key pillar of the company’s Lumada 3.0 strategy, HMAX Energy integrates digital capabilities, domain expertise, service excellence, and installed base intelligence to maximize uptime, safety, efficiency, and asset lifetime. These capabilities will empower customers to shift from reacting to predicting - future-proofing their energy infrastructure.About Hitachi, Ltd.Through its Social Innovation Business (SIB) that brings together IT, OT (Operational Technology) and products, Hitachi contributes to a harmonized society where the environment, wellbeing, and economic growth are in balance. Hitachi operates globally in four sectors – Digital Systems & Services, Energy, Mobility, and Connective Industries – and the Strategic SIB Business Unit for new growth businesses. With Lumada at its core, Hitachi generates value from integrating data, technology and domain knowledge to solve customer and social challenges. Revenues for FY2024 (ended March 31, 2025) totaled 9,783.3 billion yen, with 618 consolidated subsidiaries and approximately 280,000 employees worldwide. Visit us at https://www.hitachi.com.About Hitachi EnergyHitachi Energy is a global technology leader in electrification, powering a sustainable energy future with innovative power grid technologies with digital at the core. Over three billion people depend on our technologies to power their daily lives. With over a century in pioneering mission-critical technologies like high-voltage, transformers, automation, and power electronics, we are addressing the most urgent energy challenge of our time – balancing soaring electricity demand, while decarbonizing the power system. With an unparalleled installed base in over 140 countries, we co-create and build long-term partnerships across the utility, industry, transportation, data centers, and infrastructure sectors. Headquartered in Switzerland, we employ over 50,000 people in 60 countries and generate revenues of around $16 billion USD.https://www.hitachienergy.comhttps://www.linkedin.com/company/hitachienergyhttps://x.com/HitachiEnergyAbout Blackstone Energy Transition PartnersBlackstone Energy Transition Partners is Blackstone’s strategy for control-oriented equity investments in energy-related businesses, a leading energy investor with a successful long-term record, having committed over $27 billion of equity globally across a broad range of sectors within the energy industry. Our investment philosophy is based on backing exceptional management teams with flexible capital to provide solutions that help energy companies grow and improve performance, thereby delivering more reliable, affordable and cleaner energy to meet the needs of the global community. In the process, we build stronger, larger scale enterprises, create jobs and generate lasting value for our investors, employees and all stakeholders. Further information is available at https://www.blackstone.com/our-businesses/blackstone-energy-transition-partners/.About ShermcoHeadquartered in Irving, TX, Shermco provides electrical testing, maintenance, commissioning and repair services to a wide range of utility, industrial, energy and other end markets. With more than 40 locations, Shermco serves a diversified blue-chip client base across North America. The Company is an active participant in NETA (the InterNational Electrical Testing Association), EASA (Electrical Apparatus Service Association), and ACP (American Clean Power Association). For more information, visit www.shermco.com. Copyright 2025 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com
CMS (867.HK; 8A8.SG) NDA for AD Indication of Long-acting Anti-IL-4Ra Humanized Monoclonal Antibody Injection MG-K10 Accepted in China
SHENZHEN, Oct 30, 2025 - (ACN Newswire via SeaPRwire.com) - China Medical System Holdings Limited (“CMS”) is pleased to announce that its subsidiary, Dermavon Holdings Limited (“Dermavon”, an innovative pharmaceutical company specialized in skin health which is applying for a separate listing on the Main Board of The Stock Exchange of Hong Kong Limited, please refer to the announcement of CMS on 22 April 2025 for details) together with its subsidiaries, holds co-development rights (except for atopic dermatitis (AD)) and exclusive commercialization rights for the Class 1 innovative drug anti-IL-4Rα MG-K10 humanized monoclonal antibody injection (“MG-K10” or the “Product”). The New Drug Application (“NDA”) has been accepted by National Medical Products Administration (“NMPA”) on 30 October 2025. The product is intended for the treatment of adult with moderate-to-severe AD whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable.MG-K10 (generic name: Comekibart Injection) is an innovative long-acting anti-IL-4Rα humanized monoclonal antibody that simultaneously blocks the signaling of key type 2 inflammatory cytokines IL-4 and IL-13. With a longer half-life, the Product enables a four-week dosing frequency (currently marketed anti-IL-4Rα drugs require biweekly dosing), which is expected to improve patient adherence. MG-K10 is expected to become the world's first long-acting anti-IL-4Rα monoclonal antibody to be launched on the market, and has the potential to become the Best-in-Class (BIC).MG-K10 has achieved positive results in a randomized, double-blind, placebo-controlled Phase III clinical study in adults with moderate-to-severe AD, meeting the primary research endpoint as designed, and at 52 weeks of treatment with MG-K10, proportion of participants with Investigator Global Assessment (IGA) score of 0 or 1, also with an improvement of ≥2 points from baseline is 76.6%; proportion of participants with ≥75% reduction in Eczema Area and Severity Index (EASI 75) from baseline is 94.3 %; proportion of participants with ≥90% reduction in Eczema Area and Severity Index (EASI 90) from baseline is 79.1 %. Regarding safety, most of the Treatment Emergent Adverse Event (TEAE) were Grade 1-2, with no Adverse Event of Special Interest (AESI) or fatal adverse event occurred. The incidence of common adverse reactions (conjunctivitis, injection site reactions, etc.) of drugs with the same target is relatively low for MG-K10.The Product has the potential for the treatment of other type 2 inflammatory diseases, such as asthma, prurigo nodularis, seasonal allergic rhinitis, chronic obstructive pulmonary disease, chronic spontaneous urticaria, chronic rhinosinusitis with nasal polyps, and eosinophilic esophagitis. Among them, asthma, prurigo nodularis and seasonal allergic rhinitis have all entered the phase III clinical trial stage in China.If MG-K10 is approved, it will provide a new, effective, and safe systemic treatment option for 14.5 million patients with moderate-to-severe AD[1]. Furthermore, MG-K10 will generate synergy with Dermavon's ruxolitinib cream (for mild to moderate AD), the oral small molecule TYK2 inhibitor CMS-D001 (for moderate to severe AD), and dermatology-grade skincare products of Heling soothing product series, establishing a comprehensive solution for AD that covers various administration routes (injection, oral, and topical) and addresses multiple needs in “treatment + care”, benefiting a wide range of AD patients. Concurrently, it will further enrich Dermavon's product portfolio in the field of dermatological treatment and reinforce its leading position in skin health sector.On 24 January 2025, CMS through its subsidiaries entered into a Collaboration Agreement (“Agreement”) with Hunan Mabgeek Biotech Co., LTD and its subsidiaries for MG-K10. In accordance with the Agreement and supplementary agreements, CMS has obtained the co-development rights (excluding AD) and exclusive commercialization rights for the Product in Mainland China, Hong Kong Special Administrative Region, Macao Special Administrative Region, Taiwan Region and Singapore; its subsidiary Dermavon has obtained, through its subsidiary, the co-development rights (excluding AD) and exclusive commercialization rights for the Product in the field of dermatological indications in Mainland China.About AD IndicationMG-K10’s first indication, AD, is a chronic inflammatory skin disease accompanied by severe itching. It is the most burdensome non-fatal skin disease worldwide and also a chronic disease with a relatively high prevalence and significant disease burden in China. It is estimated that there are over 54 million AD patients in China in 2024. Based on SCORAD scores, the proportion of moderate to severe AD in China was 27%, which means there are over 14.5 million patients[1]. Due to the limitations in efficacy and safety of traditional systemic therapies for AD, moderate to severe AD patients often experience delays in systemic treatment initiation, poor compliance, and suboptimal disease control, leaving a significant unmet need in clinical practice[2]. MG-K10, with its extended dosing interval of once every four weeks, is expected to improve patient adherence and provide a new, effective, and safe systemic treatment option for patients with moderate-to-severe AD.About CMSCMS is a platform company linking pharmaceutical innovation and commercialization with strong product lifecycle management capability, dedicated to providing competitive products and services to meet unmet medical needs.CMS focuses on the global first-in-class (FIC) and best-in-class (BIC) innovative products, and efficiently promotes the clinical research, development and commercialization of innovative products, enabling the continuous transformation of scientific research into clinical practices to benefit patients.CMS deeply engages in several specialty therapeutic fields, and has developed proven commercialization capabilities, extensive networks and expert resources, resulting in leading academic and market positions for its major marketed products. CMS continues to promote the in-depth development in its advantageous specialty fields, strengthening the competitiveness of the cardio-cerebrovascular/ gastroenterology/ ophthalmology/ skin health businesses, bringing economies of scale in specialty fields. Among them, the skin health business (Dermavon) has become a leading enterprise in its field, and is proposed to be listed independently on the SEHK. Meanwhile, CMS continuously promotes the operation and development of its integrated R&D, manufacturing and commercialization chain in Southeast Asia and the Middle East, capturing growth opportunities in emerging markets to support the high-quality and sustainable development of the Group.Reference:1. China Insights Consultancy. Industry report on global and China Dermatology Treatment and Care Industry2. Chinese Society of Dermatology, China Dermatologist Association. Clinical pathway for the diagnosis and treatment of moderate to severe atopic dermatitis in China (2023): an expert consensus[J]. Chinese Journal of Dermatology, 2023, 56(11): 1000-1007. DOI: 10.35541/cjd.20230247.CMS Disclaimer and Forward-Looking StatementsThis press release is not intended to promote any products to you and is not for advertising purposes. This press release does not recommend any drugs, medical devices and/or indications. If you want to know more about the diagnosis and treatment of specific diseases, please follow the opinions or guidance of your doctor or other medical and health professionals. Any treatment-related decisions made by healthcare professionals should be based on the patient’s specific circumstances and in accordance with the drug package insert.This press release which has been prepared by CMS does not constitute any offer or invitation to purchase or subscribe for any securities, and shall not form the basis for or be relied on in connection with any contract or binding commitment whatsoever. This press release has been prepared by CMS based on information and data which it considers reliable, but CMS makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this press release. Certain matters discussed in this press release may contain statements regarding the Group’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. Any forward-looking statements and projections made by third parties included in this press release are not adopted by the Group and the Company is not responsible for such third-party statements and projections.Media ContactBrand: China Medical System Holdings Ltd.Contact: CMS Investor RelationsEmail: ir@cms.net.cnWebsite: https://web.cms.net.cn/en/home/ Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
CMS (867.HK; 8A8.SG) NDA for AD Indication of Long-acting Anti-IL-4Rα Humanized Monoclonal Antibody Injection MG-K10 Accepted in China
SHENZHEN, CHINA – October 30, 2025 – (SeaPRwire) – China Medical System Holdings Limited (“CMS”) is pleased to announce that its subsidiary, Dermavon Holdings Limited (“Dermavon”, an innovative pharmaceutical company specialized in skin health which is applying for a separate listing on the Main Board of The Stock Exchange of Hong Kong Limited, please refer to the announcement of CMS on 22 April 2025 for details) together with its subsidiaries, holds co-development rights (except for atopic dermatitis (AD)) and exclusive commercialization rights for the Class 1 innovative drug anti-IL-4Rα MG-K10 humanized monoclonal antibody injection (“MG-K10” or the “Product”). The New Drug Application (“NDA”) has been accepted by National Medical Products Administration (“NMPA”) on 30 October 2025. The product is intended for the treatment of adult with moderate-to-severe AD whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable. MG-K10 (generic name: Comekibart Injection) is an innovative long-acting anti-IL-4Rα humanized monoclonal antibody that simultaneously blocks the signaling of key type 2 inflammatory cytokines IL-4 and IL-13. With a longer half-life, the Product enables a four-week dosing frequency (currently marketed anti-IL-4Rα drugs require biweekly dosing), which is expected to improve patient adherence. MG-K10 is expected to become the world’s first long-acting anti-IL-4Rα monoclonal antibody to be launched on the market, and has the potential to become the Best-in-Class (BIC). MG-K10 has achieved positive results in a randomized, double-blind, placebo-controlled Phase III clinical study in adults with moderate-to-severe AD, meeting the primary research endpoint as designed, and at 52 weeks of treatment with MG-K10, proportion of participants with Investigator Global Assessment (IGA) score of 0 or 1, also with an improvement of ≥2 points from baseline is 76.6%; proportion of participants with ≥75% reduction in Eczema Area and Severity Index (EASI 75) from baseline is 94.3 %; proportion of participants with ≥90% reduction in Eczema Area and Severity Index (EASI 90) from baseline is 79.1 %. Regarding safety, most of the Treatment Emergent Adverse Event (TEAE) were Grade 1-2, with no Adverse Event of Special Interest (AESI) or fatal adverse event occurred. The incidence of common adverse reactions (conjunctivitis, injection site reactions, etc.) of drugs with the same target is relatively low for MG-K10. The Product has the potential for the treatment of other type 2 inflammatory diseases, such as asthma, prurigo nodularis, seasonal allergic rhinitis, chronic obstructive pulmonary disease, chronic spontaneous urticaria, chronic rhinosinusitis with nasal polyps, and eosinophilic esophagitis. Among them, asthma, prurigo nodularis and seasonal allergic rhinitis have all entered the phase III clinical trial stage in China. If MG-K10 is approved, it will provide a new, effective, and safe systemic treatment option for 14.5 million patients with moderate-to-severe AD[1]. Furthermore, MG-K10 will generate synergy with Dermavon’s ruxolitinib cream (for mild to moderate AD), the oral small molecule TYK2 inhibitor CMS-D001 (for moderate to severe AD), and dermatology-grade skincare products of Heling soothing product series, establishing a comprehensive solution for AD that covers various administration routes (injection, oral, and topical) and addresses multiple needs in “treatment + care”, benefiting a wide range of AD patients. Concurrently, it will further enrich Dermavon’s product portfolio in the field of dermatological treatment and reinforce its leading position in skin health sector. On 24 January 2025, CMS through its subsidiaries entered into a Collaboration Agreement (“Agreement”) with Hunan Mabgeek Biotech Co., LTD and its subsidiaries for MG-K10. In accordance with the Agreement and supplementary agreements, CMS has obtained the co-development rights (excluding AD) and exclusive commercialization rights for the Product in Mainland China, Hong Kong Special Administrative Region, Macao Special Administrative Region, Taiwan Region and Singapore; its subsidiary Dermavon has obtained, through its subsidiary, the co-development rights (excluding AD) and exclusive commercialization rights for the Product in the field of dermatological indications in Mainland China. About AD Indication MG-K10’s first indication, AD, is a chronic inflammatory skin disease accompanied by severe itching. It is the most burdensome non-fatal skin disease worldwide and also a chronic disease with a relatively high prevalence and significant disease burden in China. It is estimated that there are over 54 million AD patients in China in 2024. Based on SCORAD scores, the proportion of moderate to severe AD in China was 27%, which means there are over 14.5 million patients[1]. Due to the limitations in efficacy and safety of traditional systemic therapies for AD, moderate to severe AD patients often experience delays in systemic treatment initiation, poor compliance, and suboptimal disease control, leaving a significant unmet need in clinical practice[2]. MG-K10, with its extended dosing interval of once every four weeks, is expected to improve patient adherence and provide a new, effective, and safe systemic treatment option for patients with moderate-to-severe AD. About CMS CMS is a platform company linking pharmaceutical innovation and commercialization with strong product lifecycle management capability, dedicated to providing competitive products and services to meet unmet medical needs. CMS focuses on the global first-in-class (FIC) and best-in-class (BIC) innovative products, and efficiently promotes the clinical research, development and commercialization of innovative products, enabling the continuous transformation of scientific research into clinical practices to benefit patients. CMS deeply engages in several specialty therapeutic fields, and has developed proven commercialization capabilities, extensive networks and expert resources, resulting in leading academic and market positions for its major marketed products. CMS continues to promote the in-depth development in its advantageous specialty fields, strengthening the competitiveness of the cardio-cerebrovascular/gastroenterology/ophthalmology/skin health businesses, bringing economies of scale in specialty fields. Among them, the skin health business (Dermavon) has become a leading enterprise in its field, and is proposed to be listed independently on the SEHK. Meanwhile, CMS continuously promotes the operation and development of its integrated R&D, manufacturing and commercialization chain in Southeast Asia and the Middle East, capturing growth opportunities in emerging markets to support the high-quality and sustainable development of the Group. Reference: China Insights Consultancy. Industry report on global and China Dermatology Treatment and Care Industry Chinese Society of Dermatology, China Dermatologist Association. Clinical pathway for the diagnosis and treatment of moderate to severe atopic dermatitis in China (2023): an expert consensus[J]. Chinese Journal of Dermatology, 2023, 56(11): 1000-1007. DOI: 10.35541/cjd.20230247. CMS Disclaimer and Forward-Looking Statements This press release is not intended to promote any products to you and is not for advertising purposes. This press release does not recommend any drugs, medical devices and/or indications. If you want to know more about the diagnosis and treatment of specific diseases, please follow the opinions or guidance of your doctor or other medical and health professionals. Any treatment-related decisions made by healthcare professionals should be based on the patient’s specific circumstances and in accordance with the drug package insert. This press release which has been prepared by CMS does not constitute any offer or invitation to purchase or subscribe for any securities, and shall not form the basis for or be relied on in connection with any contract or binding commitment whatsoever. This press release has been prepared by CMS based on information and data which it considers reliable, but CMS makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this press release. Certain matters discussed in this press release may contain statements regarding the Group’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. Any forward-looking statements and projections made by third parties included in this press release are not adopted by the Group and the Company is not responsible for such third-party statements and projections. Media Contact Brand: China Medical System Holdings Ltd. Contact: CMS Investor Relations Email: ir@cms.net.cn Website: https://web.cms.net.cn/en/home/
Esperanza Unveils New Milestone in Tokenized Economy
HONG KONG, Oct 30, 2025 - (ACN Newswire via SeaPRwire.com) – Esperanza Fintech (Hong Kong) Limited (“Esperanza” or the “Group”) today hosted the “Conference: Implementation of Tokenized Economy by Esperanza” (“Conference”). It is an opportune moment as the Hong Kong SAR Government vows in her 2025 Policy Address to support the development of tokenized gold investment products. The Conference brought together industry leaders and partners to map out a strategic blueprint to implement tokenized economy, including the compliant roadmap for tokenized gold in Hong Kong and the unlimited potential of tokenized investments, an application for tokenized gold, in driving economic growth in the Asia-Pacific region. The Conference was attended by nearly a hundred investors and professionals.The Conference kicked off with a vision speech delivered by Mr. Ronald Leung, solicitor, Founder and Group CEO of Esperanza. Mr. Leung pointed out that the Asia-Pacific region has long relied on Western settlement systems and Western-dominated interest rate policies. The tokenized economy, powered by tokenized gold, offers an alternative capital solution to drive regional economic development and the continuous internationalization of the financial and capital markets of the Chinese Mainland and Hong Kong . He emphasized that the support for development of tokenized gold in Hong Kong’s 2025 Policy Address is a highly strategic policy direction. Capitalizing on her status and resources as an international financial center, Hong Kong possesses unparalleled edge in developing an ecosystem powered by tokenized gold in facilitating cross-border trades in the Asia-Pacific region. Furthermore, tokenized gold could be integrated with Central Bank-led digital Renminbi (RMB) in the future to contribute to the internationalization of RMB. He pointed out that the Group has completed registration with the Hong Kong Customs as an issuer of precious asset-backed instrument. The Group has also undergone a small-scale, non-public proof-of-concept (POC) testing in multiple Asia Pacific markets, including Southeast Asia, Australia, Japan, South Korea, and currently has significant verified “Know Your Customer (KYC)” POC users. Although Esperanza's tokenized gold is designed based on the legal framework for precious asset-backed instrument registered with Hong Kong Customs, to ensure overall regulatory stability in Hong Kong, it is anticipated that Esperanza will open its tokenized gold offerings to the Hong Kong public only after addressing the concerns of other regulatory bodies and when a clear regulatory framework is fully implemented in the city. The Group will also align with governments of various economies on operational fronts via strategic partners.Mr. Leung continued to point out, "Tokenized gold is a key milestone for Hong Kong's financial future. Esperanza has already signed an agreement with Hatcher Group Limited (8365.HK) regarding the development of tokenized gold before the Policy Address was released. Immediately following the release, our team has conducted a productive and in-depth communication with the Chief Executive's Policy Unit, while ensuring our technology platform and infrastructure are in place and ready for action. Currently, we are maintaining active dialogues with regulators, with the core principle of achieving ‘controllable innovation’ that adheres to existing regulatory framework as well as the work agenda of the Chief Executive’s Policy Unit. We firmly believe that Esperanza, armed with first-mover advantages in technology and its business model, and in collaboration with various sectors, will be able to transform tokenized gold into a powerful engine in driving economic autonomy in the Asia-Pacific region."The conference had two thematic sharing sessions. The first had Mr. Roy Lui, Managing Director of ESPE Gold Solutions, sharing the compliant implementation of tokenized gold in Hong Kong. Mr. Lui shared that the Group’s proposed solution – “ESPE Gold” (“ESPG”) – is legally categorized as a “precious asset-backed instrument” instead of a virtual asset or a stablecoin, nor a collective investment scheme. Esperanza purchases physical gold bars adhering to London Bullion Market Association (LBMA) standards, stores them in licensed gold vaults and issues 100,000 ESPG, i.e. digital gold certificates, for each kilogram of gold bar. These digital gold certificates, each representing a complete instalment payment, are recorded on blockchain networks. Upon completion of 100,000 instalments, i.e. holding 100,000 ESPG, clients can redeem physical gold bars from Esperanza. Clients can make instalment payments any time and sell ESPG back to Esperanza, enjoying much higher flexibility than traditional gold redemption clubs. Mr. Lui emphasized that, although ESPG gives users experiences similar to that of stablecoins, the business model is actually more akin to traditional gold dealers earning bid-ask spread. He also spoke on the diverse application scenarios of ESPG besides as a convenient way to purchase physical gold. ESPG is poised to develop into a cross-border settlement means for commerce across Asia economies, with future potential to power a gold-backed interest rate system through collateralized lending of ESPG.In the second sharing session, Mr. Tony Chang, Executive Director of ESPE Capital Solutions, talked about the Group’s blueprint for tokenized investments as a core use case for tokenized gold. Mr. Chang said tokenized investments have not seen significant breakthrough due to the lack of product designs that are attractive to investors and that liquidity is highly concentrated within professional investors. Tokenized investments need to deliver both “attractive growth potential” and “security in exit channels” in order for investors to make meaningful consideration for adoption. Such example includes a short-term revenue sharing arrangement with foreseeable potential for revenue improvement. He added that Esperanza has obtained the Asset Management licence from the Securities and Futures Commission (SFC) of Hong Kong and its application for tokenized business is currently under review, with the legal, tax, and trading infrastructures ready. Currently, the Group’s tokenized investment pipelines include concert revenue of Southeast Asian and Korean artists, movie box office receipts and revenue of hotels and shopping malls.In addition to the thematic sharing sessions, the conference also featured a panel discussion comprising Mr. Jeremy Teo from Singapore, Co-founder and Board Director of Esperanza, Mr. Ronald Leung and Mr. Tony Chang. The discussion centers on the development potential of tokenized gold and tokenized investments across various Asia-Pacific economies, particularly the opportunities in bringing Southeast Asian projects to Hong Kong for capital raising via security token offerings (STOs). These opportunities illustrate the advantages for Hong Kong in developing tokenized gold with the support of the Hong Kong SAR Government.The conference marked an important step made by Esperanza in promoting the development of tokenized economy in Hong Kong and across Asia. Looking ahead, the Group will continue to provide innovative fintech solutions to support Hong Kong in strengthening her position as an international financial center, as well as helping foster greater economic autonomy and financial innovation in the Asia-Pacific region.Photo captionsPhoto 1: (From left to right) Mr. Tony Chang, Executive Director of ESPE Capital Solutions, and Mr. Ronald Leung, Founder and Group CEO of Esperanza, and Mr. Roy Lui, Managing Director of ESPE Gold Solutions, at the conference.Photo 2: (From left to right) Mr. Jeremy Teo, Co-founder and Board Director of Esperanza, Mr. Ronald Leung, Founder and Group CEO of Esperanza, and Mr. Tony Chang, Executive Director of ESPE Capital Solutions, after the panel discussion session.About Esperanza Fintech (Hong Kong) Limited (Esperanza)Esperanza is co-founded by the next generation of professionals from Hong Kong and Singapore with the mission to reform Asia’s economies through fintech. Esperanza is building the world’s first digital economy powered by a compliant tokenized gold infrastructure and its applications in finance. Esperanza aspires to reconnect Asia’s economies and integrate with their respective Central Bank Digital Currencies (CBDCs) to build autonomy against reliance on Western settlement systems and interest rate policies.Esperanza operates on a low-profile, highly efficient, and decisive business model. Since commencement in 2025, Esperanza has secured the registration as a Precious Metals and Stones Dealer (DPMS) with Hong Kong Customers and the Trust or Company Service Provider (TCSP) licence for the operations and custody of tokenized gold, and the Asset Management licence with the Securities and Futures Commission (SFC) of Hong Kong for the development of tokenized investments.In August 2025, Esperanza entered into a partnership agreement with Hatcher Group (8365.HK) relating to tokenized gold and tokenized investments. In September 2025, Hong Kong government has included the development of tokenized gold into its 2025 Policy Address.Esperanza's tokenized gold and tokenized investments continue to adhere to Hong Kong's Anti-Money Laundering (AML) requirements and common reporting standard for counter-tax evasion measures. Fintech solutions have enabled Esperanza to significantly reduce financing and operational costs, connecting products directly with end users. Esperanza’s tokenized finance system will fully support the globalization of national economy and is committed to becoming an alternative solution for international trades and settlements.To find out more, please visit the Esperanza website: espetopia.com Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
Bank Street Mortgage: កំណត់និយមន័យថ្មីនៃតួនាទីរបស់ឈ្មួញកណ្តាលកម្ចីទិញផ្ទះនៅអូតាវ៉ា
(SeaPRwire) - Bank Street Mortgage គឺជាអ្នកសម្របសម្រួលកម្ចីទិញផ្ទះដ៏លេចធ្លោមួយនៅ OttawaOttawa, Ontario ថ្ងៃទី 29 ខែតុលា ឆ្នាំ 2025 - Bank Street Mortgage ដែលជាឈ្មោះដែលគួរឱ្យទុកចិត្តរបស់ Ottawa ក្នុងការផ្តល់ហិរញ្ញប្បទានផ្ទះ ដ៏មានមោទនភាពក្នុងការប្រកាសពីការប្តេជ្ញាចិត្តជាបន្តបន្ទាប់របស់ខ្លួន ក្នុងការជួយអ្នកទិញផ្ទះ និងវិនិយោគិនអចលនទ្រព្យស្វែងរកដំណោះស្រាយកម្ចីទិញផ្ទះល្អបំផុតដែលសមស្របនឹងគោលដៅហិរញ្ញវត្ថុរបស់ពួកគេ។ ក្នុងនាមជាអ្នកសម្របសម្រួលកម្ចីទិញផ្ទះឈានមុខគេនៅ Ottawa, Bank Street Mortgage កំពុងកំណត់ស្តង់ដារថ្មីក្នុងការបង្ហាញតម្លាភាព ភាពងាយស្រួល និងការណែនាំផ្នែកហិរញ្ញវត្ថុផ្ទាល់ខ្លួន។ ជាមួយនឹងទីផ្សារអចលនទ្រព្យនៅ Ottawa កាន់តែមានការប្រកួតប្រជែង ការស្វែងរកកម្ចីទិញផ្ទះដែលត្រឹមត្រូវអាចជាការលំបាក។ Bank Street Mortgage បំពេញចន្លោះនេះដោយភ្ជាប់អតិថិជនជាមួយអ្នកផ្តល់កម្ចីកំពូលៗទូទាំងប្រទេសកាណាដា ធានាថាពួកគេទទួលបាន អត្រាកម្ចីទិញផ្ទះល្អបំផុត និងលក្ខខណ្ឌបត់បែន ដើម្បីបំពេញតាមតម្រូវការបុគ្គលរបស់ពួកគេ។ "[បញ្ចូលឈ្មោះអ្នកនាំពាក្យ], [តំណែង] នៅ Bank Street Mortgage បានថ្លែងថា៖ "បេសកកម្មរបស់យើងតែងតែជាការសម្រួលដំណើរការកម្ចីទិញផ្ទះ។ យើងយល់ថាការទិញ ឬពង្រាយកម្ចីផ្ទះឡើងវិញ គឺជាការសម្រេចចិត្តផ្នែកហិរញ្ញវត្ថុដ៏ធំបំផុតមួយក្នុងជីវិត។ នោះហើយជាមូលហេតុដែលយើងមានមោទនភាពក្នុងការផ្តល់ដំបូន្មានពីអ្នកជំនាញ ការអនុម័តរហ័ស និងការទទួលបានជម្រើសកម្ចីទិញផ្ទះដែលមានការប្រកួតប្រជែងបំផុតដែលមាននៅក្នុងទីផ្សារ Ottawa"។ មិនថាអតិថិជនជា អ្នកទិញផ្ទះលើកដំបូង វិនិយោគិនអចលនទ្រព្យ ឬអ្នកដែលកំពុងស្វែងរក ការពង្រាយកម្ចីទិញផ្ទះដែលមានស្រាប់របស់ពួកគេឡើងវិញ នោះ Bank Street Mortgage ផ្តល់ជូននូវសេវាកម្មពេញលេញ រួមមាន៖ ដំណោះស្រាយកម្ចីទិញផ្ទះលំនៅដ្ឋាន និងពាណិជ្ជកម្ម ការអនុម័តជាមុន និងការពង្រាយកម្ចីទិញផ្ទះឡើងវិញ ជម្រើសបង្រួបបង្រួមបំណុល ការទទួលបានកម្មវិធីផ្តល់កម្ចីផ្តាច់មុខ ដំបូន្មានអ្នកជំនាញលើកម្ចីអត្រាការប្រាក់ថេរ និងអត្រាការប្រាក់អណ្ដែត ក្នុងនាមជាក្រុមហ៊ុនប្រតិបត្តិការក្នុងស្រុក Bank Street Mortgage ទទួលយកវិធីសាស្រ្តផ្ដោតលើអតិថិជន ដោយផ្តល់ជូននូវដំណោះស្រាយហិរញ្ញវត្ថុផ្ទាល់ខ្លួន និងការគាំទ្រអតិថិជនពិសេស។ ក្រុមអ្នកសម្របសម្រួលកម្ចីទិញផ្ទះដែលមានបទពិសោធន៍របស់ក្រុមហ៊ុន ប្រើប្រាស់ទំនាក់ទំនងយូរអង្វែងជាមួយធនាគារធំៗ សហជីពឥណទាន និងអ្នកផ្តល់កម្ចីឯកជន ដើម្បីធានាលទ្ធផលល្អបំផុតសម្រាប់អតិថិជនរបស់ពួកគេ។ អ្នកទិញផ្ទះ និងវិនិយោគិននៅ Ottawa ដែលស្វែងរកការណែនាំកម្ចីទិញផ្ទះដែលអាចទុកចិត្តបាន ឥឡូវនេះអាចចូលទៅកាន់ Bank Street Mortgage ដើម្បីស្វែងយល់ពីសេវាកម្មដែលមាន គណនាការបង់កម្ចីទិញផ្ទះ ឬកំណត់ពេលពិគ្រោះយោបល់ដោយឥតគិតថ្លៃ។ អំពី Bank Street Mortgage Bank Street Mortgage គឺជាអ្នកផ្តល់សេវាដ៏ឆ្នើមមួយ ដែលឧទ្ទិសដល់ការជួយអតិថិជនឱ្យសម្រេចបាននូវក្តីសុបិននៃការធ្វើជាម្ចាស់ផ្ទះ និងការវិនិយោគរបស់ពួកគេ។ ជាមួយនឹងការណែនាំផ្នែកហិរញ្ញវត្ថុពីអ្នកជំនាញ បណ្តាញអ្នកផ្តល់កម្ចីដ៏ធំទូលាយ និងវិធីសាស្រ្តផ្ដោតលើអតិថិជន, Bank Street Mortgage ផ្តល់នូវដំណោះស្រាយកម្ចីទិញផ្ទះតាមតម្រូវការដែលធ្វើឱ្យការផ្តល់ហិរញ្ញប្បទានផ្ទះកាន់តែងាយស្រួល លឿន និងមានតម្លៃសមរម្យ។ទំនាក់ទំនងប្រព័ន្ធផ្សព្វផ្សាយbank street mortgage ប្រភព :Bank Street Mortgage អត្ថបទនេះត្រូវបានផ្តល់ជូនដោយអ្នកផ្គត់ផ្គង់មាតិកាដែលទីបញ្ចូល។ SeaPRwire (https://www.seaprwire.com/) មិនមានការធានា ឬ បញ្ចេញកំណត់ណាមួយ។ ប្រភេទ: ព័ត៌មានប្រចាំថ្ងៃ, ព័ត៌មានសំខាន់ SeaPRwire ផ្តល់សេវាកម្មផ្សាយពាណិជ្ជកម្មសារព័ត៌មានសកលសម្រាប់ក្រុមហ៊ុន និងស្ថាប័ន ដែលមានការចូលដំណើរការនៅលើបណ្ដាញមេឌៀជាង 6,500 បណ្ដាញ ប័ណ្ណប្រតិភូ 86,000 និងអ្នកសារព័ត៌មានជាង 350 លាន។ SeaPRwire គាំទ្រការផ្សាយពាណិជ្ជកម្មជាសារព័ត៌មានជាភាសាអង់គ្លេស ជប៉ុន ហ្រ្វាំង គូរី ហ្វ្រេនច រ៉ុស អ៊ីនដូនេស៊ី ម៉ាឡេស៊ី វៀតណាម ចិន និងភាសាផ្សេងទៀត។
Husaina Metal Industries ពង្រីកការផលិតទំពក់លួសដែកសម្រាប់បោកគក់ ដើម្បីបម្រើអាជីវកម្មនានានៅក្នុង GCC
(SeaPRwire) - Husaina Metal Industries បង្កើនសមត្ថភាពផលិតទំពក់សម្លៀកបំពាក់លោហៈធំៗ ដើម្បីបំពេញតម្រូវការលក់ដុំដែលកំពុងកើនឡើងពីហាងបោកអ៊ុត និងអ្នកផ្តល់សេវាសម្លៀកបំពាក់។ រ៉ាស់ អាល់ កៃម៉ាស់ (Ras al-Khaymah), អារ៉ាប់រួម (United Arab Emirates) ថ្ងៃទី ២៩ ខែ តុលា ឆ្នាំ ២០២៥ - Husaina Metal Industries LLC ដែលជាឈ្មោះលេចធ្លោក្នុងការផលិតខ្សែដែកទូទាំងប្រទេសអារ៉ាប់រួម បានប្រកាសពីការពង្រីកសមត្ថភាពយ៉ាងសំខាន់ក្នុងការផលិតសម្រាប់ហាងបោកអ៊ុត ហាងអ៊ុតស្ងួត (dry cleaners) និងអ្នកនាំចេញសម្លៀកបំពាក់ដែលស្វែងរកដំណោះស្រាយទំពក់ដែលមានបរិមាណច្រើន និងគួរឱ្យទុកចិត្ត។ ការផ្លាស់ប្តូរនេះកើតឡើងនៅពេលដែលទីផ្សារក្នុងតំបន់ និងនាំចេញកំពុងឃើញតម្រូវការកើនឡើងសម្រាប់ទំពក់ដែកដែលមានកម្លាំងខ្ពស់ ឯកសណ្ឋាន និងសមរម្យសម្រាប់ការប្រើប្រាស់ឧស្សាហកម្មជាបន្តបន្ទាប់។ គ្រឿងបរិក្ខារដែលបានធ្វើឱ្យប្រសើរឡើងរបស់ Husaina រួមបញ្ចូលបច្ចេកវិទ្យាទម្រង់ភាពជាក់លាក់ និងការស្រោបដោយស្វ័យប្រវត្តិ ធានានូវគុណភាពជាប់លាប់លើទំពក់ដែកដែលមានគុណភាពខ្ពស់ទាំងអស់ ខណៈពេលដែលរក្សាបានតម្លៃសមរម្យសម្រាប់អ្នកទិញទ្រង់ទ្រាយធំ។ យោងតាមប្រភពពីក្រុមហ៊ុន ការពង្រីកនេះនឹងបង្កើនប្រសិទ្ធភាពផលិតកម្មលើសពី ៣០% ដែលអនុញ្ញាតឱ្យ Husaina អាចបំពេញការបញ្ជាទិញក្នុងស្រុក និងអន្តរជាតិបានទាន់ពេលវេលា។ ក្រុមហ៊ុនបន្តផ្តល់អាទិភាពដល់និរន្តរភាពដោយការផលិតដោយប្រើប្រាស់វត្ថុធាតុដែលអាចកែច្នៃបាន និងដំណើរការដែលប្រកបដោយប្រសិទ្ធភាពថាមពល។ "អតិថិជនអាជីវកម្មសព្វថ្ងៃរំពឹងទុកទាំងភាពជឿជាក់ និងតម្លៃសមរម្យ" បាននិយាយ Ismail Badri សម្រាប់ Husaina Metal Industries LLC។ "ការយកចិត្តទុកដាក់របស់យើងលើទំពក់ដែកគឺជាផ្នែកមួយនៃយុទ្ធសាស្ត្រទូលំទូលាយដើម្បីពង្រឹងសមត្ថភាពផ្គត់ផ្គង់របស់យើងសម្រាប់ខ្សែសង្វាក់ហាងបោកអ៊ុត សេវាឯកសណ្ឋាន និងផ្នែកលទ្ធកម្មសណ្ឋាគារ។" នៅក្នុងឧស្សាហកម្មដែលកាន់តែជំរុញដោយប្រសិទ្ធភាព និងភាពធន់ ទំពក់ដែកភាគច្រើននៅតែជាជម្រើសជាក់ស្តែងសម្រាប់កន្លែងបោកអ៊ុតដែលមានបរិមាណច្រើន។ ពួកវាផ្តល់នូវភាពឯកសណ្ឋានក្នុងការបង្ហាញសម្លៀកបំពាក់ កាត់បន្ថយការខូចទ្រង់ទ្រាយ និងកាត់បន្ថយកាកសំណល់ប្រតិបត្តិការបើប្រៀបធៀបទៅនឹងជម្រើសប្លាស្ទិក។ ខ្សែផលិតផលរបស់ Husaina Metal Industries LLC ត្រូវបានបង្កើតឡើងសម្រាប់ភាពធន់ និងការបញ្ចប់ប្រកបដោយវិជ្ជាជីវៈ -- ដែលជាទិដ្ឋភាពសំខាន់ៗដែលទាក់ទាញអតិថិជនពាណិជ្ជកម្មដែលពឹងផ្អែកលើវដ្តបន្តបន្ទាប់នៃការបោកគក់ ចុច (pressing) និងដឹកជញ្ជូនសម្លៀកបំពាក់។ ជាមួយនឹងកេរ្តិ៍ឈ្មោះដែលបានបង្កើតឡើងសម្រាប់ភាពជាក់លាក់ និងសេវាកម្ម Husaina Metal Industries LLC បន្តពង្រីកវត្តមានរបស់ខ្លួនទូទាំង GCC ដោយផ្តល់ឱ្យអតិថិជននូវការចូលទៅកាន់ជំនាញផលិតកម្មដោយផ្ទាល់ និងការធានាការផ្គត់ផ្គង់ច្រើនតាមរយៈ អំពី Husaina Metal Industries LLC មានមូលដ្ឋាននៅទីក្រុងឌូបៃ (Dubai) ក្រុមហ៊ុន Husaina Metal Industries LLC ផលិត និងផ្គត់ផ្គង់ផលិតផលខ្សែដែកលំដាប់ខ្ពស់ទៅកាន់វិស័យជាច្រើន ដោយផ្តោតជាពិសេសលើទំពក់ដែកលក់ដុំ ទម្រង់ខ្សែដែកឧស្សាហកម្ម និងដំណោះស្រាយតាមតម្រូវការសម្រាប់អតិថិជនពាណិជ្ជកម្ម។ទំនាក់ទំនងប្រព័ន្ធផ្សព្វផ្សាយHusaina Metal Industries072267862រ៉ាស់ អាល់ កៃម៉ាស់ (Ras Al Khaimah) ប្រភព :Husaina Metal Industries – Premium Wire & Metal Solutions for Industrial and Commercial Needs អត្ថបទនេះត្រូវបានផ្តល់ជូនដោយអ្នកផ្គត់ផ្គង់មាតិកាដែលទីបញ្ចូល។ SeaPRwire (https://www.seaprwire.com/) មិនមានការធានា ឬ បញ្ចេញកំណត់ណាមួយ។ ប្រភេទ: ព័ត៌មានប្រចាំថ្ងៃ, ព័ត៌មានសំខាន់ SeaPRwire ផ្តល់សេវាកម្មផ្សាយពាណិជ្ជកម្មសារព័ត៌មានសកលសម្រាប់ក្រុមហ៊ុន និងស្ថាប័ន ដែលមានការចូលដំណើរការនៅលើបណ្ដាញមេឌៀជាង 6,500 បណ្ដាញ ប័ណ្ណប្រតិភូ 86,000 និងអ្នកសារព័ត៌មានជាង 350 លាន។ SeaPRwire គាំទ្រការផ្សាយពាណិជ្ជកម្មជាសារព័ត៌មានជាភាសាអង់គ្លេស ជប៉ុន ហ្រ្វាំង គូរី ហ្វ្រេនច រ៉ុស អ៊ីនដូនេស៊ី ម៉ាឡេស៊ី វៀតណាម ចិន និងភាសាផ្សេងទៀត។
MHI-MS to Conduct Demonstration Testing of Vehicle Transport Robots at Nakagusuku Port in Okinawa
Vehicle transport robotsTOKYO, October 30, 2025 - (JCN Newswire via SeaPRwire.com) - Mitsubishi Heavy Industries Machinery Systems (MHI-MS), a part of Mitsubishi Heavy Industries (MHI) Group, will conduct demonstration testing of finished vehicle logistics (FVL) using vehicle transport robots to autonomously move automobiles. Following a proposal adopted for "Testbed Support Subsidy Program"(*1) conducted by Okinawa Prefecture, demonstration testing is scheduled to begin on December 1 this year at the prefecture's temporary vehicle storage yard (motor pool) at Nakagusuku Port (Uruma, Okinawa Prefecture).Vehicle transport robots are used to autonomously move finished vehicles at automobile manufacturing plants, motor pools, and for automated valet parking at shopping malls, theme parks, and airports.(*2) The system enables automated transport even if the vehicle itself is not equipped with autonomous driving capabilities or communication functions, and can be widely utilized in motor pools for both new and used cars without the need for vehicle modification or extensive installation of equipment on the infrastructure side, and without major changes to current operations.MHI-MS has been jointly developing the first advanced automated transport robot business in Japan with Stanley Robotics, a French venture company, since 2021. As of October 2025, seven core patents have been registered in Japan for automated transport robots, which will drive market expansion. In consideration of the unique conditions in Japan, domestic development of a customizable system was completed in March this year.Okinawa, the site of the demonstration testing for finished vehicle transport, is a region with a high rate of private car ownership, with the number of private cars owned per capita of the population over the age of 20 exceeding the national average. Used cars especially are preferred by many prefectural residents because they are less expensive than new cars, and play an important role in the infrastructure supporting everyday life. In addition, because of the many tourist arrivals in Okinawa from Japan and abroad, the number of rental car registrations is one of the highest in Japan. Registered rental cars are replaced every few years and sold on the market as used cars. In this way, the used car market supports Okinawa's industry and the everyday lives of people.The Nakagusuku Port Motor Pool is mainly used for temporary storage of used cars prior to shipping, and transport services such as the loading and unloading of used cars are conducted at the site on a regular basis. In addition, the outdoor work environment has become harsher due to global warming, so reducing the physical burden on workers and ensuring a sustainable working style is an urgent matter. Strategies to address labor shortages due to the declining birth rate and aging population have also become a concern. In addition, the application of DX (digital transformation) technologies for vehicle management, such as visualization of the storage location of used cars, was also a factor for future consideration.MHI-MS decided to participate in this program in Okinawa Prefecture to demonstrate the effectiveness of vehicle transport robots as a solution to such challenges. The demonstration testing will evaluate the potential for improving the working environment, and responding to labor shortages, as well as "human-centered robot utilization" such as robot-based yard management systems and DX to handle vehicle location information. The tests will also evaluate the potential contribution to decarbonization efforts by confirming supplemental benefits such as curbing CO2 emissions through reduced driving of gasoline-powered vehicles.Going forward, as a company committed to creating new value for society and solving future societal issues through mechatronics, MHI-MS will establish a new future for finished vehicle transport that is friendly to both people and the planet.(*1) "Testbed Support Subsidy Program (Okinawa Prefecture Subsidy Program)" provides support for proof-of-concept experiments within Okinawa Prefecture by companies with innovative digital technologies and services, with the aim of furthering innovation and solutions to societal issues. See the following website for more information about the program. https://testbedislandokinawa.com (Japanese)(*2) When the driver stops at a designated berth close to the facility, the vehicle transport robot moves the vehicle to a vacant space, taking over parking on behalf of the driver. The process is reversed when retrieving the vehicle, with the robot transporting the vehicle back to the berth at the time specified by the driver in advance using the smartphone app. For drivers, there is no need to find a parking space or park, and no concerns about brushing against the adjacent car when opening the door.About MHI GroupMitsubishi Heavy Industries (MHI) Group is one of the world’s leading industrial groups, spanning energy, smart infrastructure, industrial machinery, aerospace and defense. MHI Group combines cutting-edge technology with deep experience to deliver innovative, integrated solutions that help to realize a carbon neutral world, improve the quality of life and ensure a safer world. For more information, please visit www.mhi.com or follow our insights and stories on spectra.mhi.com Copyright 2025 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com
Everest Medicines Acquires Exclusive Greater China and Other Asian Country Rights to VIS-101, a Novel Bifunctional Biologic for Serious Eye Disorders
HONG KONG, Oct 30, 2025 - (ACN Newswire via SeaPRwire.com) – Everest Medicines (HKEX:1952.HK) today announced that it has acquired an exclusive license with Visara, Inc. (“Visara”), a subsidiary of NovaBridge Biosciences (formally known as I-Mab, and is a company listed on the Nasdaq Global Market trading under the symbol “NBP”), to secure an exclusive license to develop, manufacture and commercialize VIS-101, in Greater China, Singapore, South Korea and certain Southeast Asian countries.This collaboration marks Everest’s strategic expansion into ophthalmology, a high-potential “blue-ocean” therapeutic area, further enriching its late-stage product pipeline and strengthening synergies across its core therapeutic portfolio.Under the assigned exclusive license, Everest Medicines will make an upfront payment of US$7 million (equivalent to approximately RMB49.7 million) and reimburse up to RMB24.0 million for prior expenses; and pay up to US$89.0 million (equivalent to approximately RMB632.0 million) in potential milestones; plus tied royalties on net sales.“We are pleased to collaborate with Visara. This partnership brings a highly differentiated and commercially attractive asset to Everest’s late-stage product pipeline and marks our entry into ophthalmology, a competitively attractive therapeutic area with significant unmet medical needs,” said Rogers Yongqing Luo, Chief Executive Officer of Everest Medicines. “Leveraging Everest’s clinical development and commercialization expertise, we look forward to advancing VIS-101, a potential best-in-class bifunctional antibody, towards commercialization in China and across Asia.”VIS-101 is a novel bifunctional biologic targeting VEGF-A and ANG-2 that is more potent and could potentially provide more durable treatment benefits than existing treatments for patients with wet age-related macular degeneration, diabetic macular edema, and retinal vein occlusion. VIS-101 has completed initial safety and dose-escalation studies in both the United State of America and China, and is currently completing a randomized, dose-ranging Phase 2 study in China. VIS-101 is anticipated to be Phase 3-ready in 2026.“VIS-101 is anticipated to be second-in-class with best-in-class potential, based on bioengineered, superior target neutralizing capabilities.” said Dr. Emmett T. Cunningham, Jr, Co-Founder and Executive Chairman of Visara.Globally, the market size for anti-VEGF ophthalmic drugs reached approximately USD 23 billion in 2024 and is projected to exceed USD 40 billion by 2030. In China alone, the prevalent patient population of AMD and DME exceeds 15 million, with around 600,000 new cases each year, yet only about 500,000 patients currently receive treatment. This indicates vast market potential.Visara is a subsidiary of NovaBridge Biosciences (Nasdaq: NBP), of which Everest Medicines is currently the largest shareholder. “Licensing out Greater China, South Korea and Southeast Asia rights to Everest Medicines is an important step toward streamlining global commercial rights and creating synergy in global clinical development,” said Dr. Sean Fu, Chief Executive Officer of NovaBridge Biosciences. “We are excited to work with Everest Medicines team as a strategic partner."Under its “dual-engine” strategy, Everest Medicines has established a commercialization platform anchored by two blockbuster products targeting high-potential markets and powered by the in-house in vivo CAR-T and mRNA therapeutic cancer vaccine platforms. The Company will continue to focus on key therapeutic areas and new growth markets, with ophthalmology as the next growth driver to strengthen synergy across its core portfolio.Everest’s core product pipeline in rental diseases, infectious diseases, and autoimmune disorders has entered a critical growth stage. NEFECON® and XERAVA® have established sustainable commercial cash flow generation, while VELSIPITY® (etrasimod) is expected to become the company’s next blockbuster product. Everest continues to enhance its innovation capability and long-term competitiveness by leveraging its industry-leading mRNA therapeutic cancer vaccine platform and mRNA in vivo CAR-T platform.At a recent corporate strategy meeting, Everest Medicines announced plans to in-license more than three high-potential assets within the next 6–12 months, with an aggregate domestic peak sales potential exceeding RMB10 billion. Combined with its existing portfolio, Everest Medicines expects its total domestic peak sales potential to surpass RMB20 billion. Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
DENSO Hosted a Press Briefing at JAPAN MOBILITY SHOW 2025
KARIYA, JAPAN, Oct. 30, 2025 - (JCN Newswire via SeaPRwire.com) - DENSO CORPORATION hosted a press briefing at JAPAN MOBILITY SHOW 2025 held at Tokyo Big Sight on October 30. Shinnosuke Hayashi, President & CEO, DENSO CORPORATIONFull transcript of the speech------------------------------Good morning, I’m Shinnosuke Hayashi from DENSO.Thank you very much for joining us today.Since its founding, DENSO’s journey has evolved alongside the automobile. By focusing on the environment and safety, we have addressed social challenges and expanded our product domains from starter and alternator systems to powertrain, body, thermal, and safety products—covering a wide range of core vehicle functions.To ensure vehicle performance and reliability, we have also pursued deep technological expertise in each domain, evolving our offerings from components to systems.This breadth and depth of technology are unique strengths of DENSO, supporting both the evolution of automobiles and the future of mobility.Today, the world is steadily moving toward carbon neutrality. In the automotive industry, reducing environmental impact and responding to increasingly diverse powertrains have become key challenges.Leveraging our fuel efficiency and emission reduction technologies, along with our electrification expertise, DENSO continues to tackle these challenges by offering products for engine vehicles, HEVs, PHEVs, battery EVs, and FCEVs.Now, we are pleased to announce the development of a new inverter—the core component of electric vehicles.The key to inverter performance lies in semiconductor and cooling technologies.Through extensive R&D—from circuit design to manufacturing processes—we’ve realized a proprietary 3D structure on SiC(silicon carbide) semiconductor wafers, maximizing power efficiency. Additionally, by applying cooling technologies cultivated through car air conditioning systems, we’ve achieved a flat, double-sided cooling structure for the power card. By optimally integrating these technologies as a system, we have reduced power loss by 70% and downsized the core module by about 30% compared to conventional products.This results in the world’s highest power density, contributing to improved energy efficiency across the vehicle.Meanwhile, in the era of Software-Defined Vehicles (SDVs), vehicle intelligence is accelerating through advanced driver assistance and autonomous driving. System-on-Chip (SoC) semiconductors are gaining attention as high-performance digital components capable of running sophisticated software.Unlike general-purpose SoCs, automotive SoCs must withstand harsh conditions unique to vehicles.For over half a century, DENSO has tackled technical challenges such as heat, noise, and vibration in semiconductor development.Building on this experience, we are developing original SoCs that deliver high performance and reliability tailored to automotive needs.We are also advancing the development of an “Integrated Mobility Computer” that controls multiple domains across the vehicle, leveraging our expertise in ECU development across all areas.This computer will help accelerate the spread of vehicle intelligence, contributing to safer and more comfortable mobility for more users.We aim to launch the Integrated Mobility Computer equipped with our original SoC in 2029.Production is planned at our next-generation factory in Aichi Prefecture (Zenmyo Plant), which will use advanced technologies to operate 24 hours a day.DENSO will extend its efforts toward the environment and safety beyond the evolution of automobiles to encompass the entire mobility society.At this year’s Japan Mobility Show, we are showcasing initiatives that expand these efforts to society —such as energy management across entire cities and safe, comfortable mobility realized through vehicles connected to society.We invite you to visit our exhibits and experience the future of mobility with DENSO.“With refined technology, we open the future.”We have taken on numerous challenges through the power of technology.The driving force behind this is the passion of the people involved in manufacturing.DENSO will continue to unite the passion of our employees, and together with automakers and many partners who share our vision for the future, we will keep taking on new challenges.Thank you very much for your attention.-------------------------Videos and images from the press conference are also available at the link below. https://www.denso.com/global/en/about-us/corporate-info/press-info Copyright 2025 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com
Gannon & Scott has signed a definitive agreement to join Metalor Technologies
Cranston, RI, USA & Neuchâtel, Switzerland, Oct 29, 2025 - (JCN Newswire via SeaPRwire.com) - Gannon & Scott, a leading provider of precious metal refining and recovery services in North America, today announced that it has signed a definitive agreement to join Metalor Technologies, one of the most respected names in the global precious metals industry and part of TANAKA. The transaction is expected to close following approval by regulatory authorities, after which Gannon & Scott will become a wholly owned subsidiary of Metalor Technologies, enhancing the capabilities of both organizations and positioning them to better serve their worldwide customer base.Founded in 1919, Gannon & Scott has earned a strong reputation for secure, environmentally responsible refining solutions across industries including electronics, aerospace, electroplating, medical devices, and jewelry manufacturing. With facilities in Rhode Island and Arizona, the company is recognized for its proprietary thermal reduction technology and waste minimization processes — innovations that align seamlessly with Metalor Technologies’ global standards for excellence.“We are thrilled to become part of an organization that shares our commitment to innovation, customer success, and sustainable growth,” said Christopher Jones, President of Gannon & Scott. “This partnership allows us to build on our strengths while gaining new resources and opportunities. Together, we are well positioned to deliver even greater results for our customers, employees, and partners.”A Stronger Offering for CustomersAs part of Metalor Technologies, Gannon & Scott customers will benefit from:Expanded refining capabilities across all precious metals (gold, silver, platinum, palladium, rhodium, iridium, ruthenium) through global sourcing and recycling channels.Access to high-purity precious metals, technical products, compounds, and chemicals. Advanced technology and analytical services powered by Metalor Technologies’ international laboratories and R&D network.A global refining infrastructure enabling more agile service to international operations.“Since 1919, Gannon & Scott has consistently grown. Becoming part of Metalor Technologies provides a tremendous opportunity to accelerate that growth,” said Joe Peixoto, CEO of Gannon & Scott. “It opens the door to new capabilities, new markets, and new professional development opportunities for our employees. Our customers can be assured that the high level of service, trust, and security they’ve always relied on will remain unchanged — now strengthened by access to a broader suite of products and services.”Customers can expect a seamless transition. In particular, Gannon & Scott’s leadership team, skilled workforce, facilities, and day-to-day operations will remain unchanged.“The acquisition of Gannon & Scott, the most reputable secondary refiner in the United States, represents a strategic step in strengthening Metalor Technologies’ vertical integration,” said Nicolas Carrera, CEO of Metalor Technologies. “By securing direct access to low-grade materials such as electronic waste, we reinforce our commitment to sustainable sourcing and responsible recycling of precious metals, while expanding our ability to serve customers and partners with greater efficiency and environmental responsibility.”“Joining the forces of Gannon & Scott with our existing refining operations in the United States, which have recently begun refining PGMs, will significantly enhance our ability to serve the American market,” said Dr. Yuxing Shang, President of Metalor Technologies’ Refining Group. “This integration allows us to expand the range of services we can offer to both current and future customers in North America, combining advanced capabilities with the trusted expertise of Gannon & Scott.”“We warmly welcome the collaboration between Gannon & Scott and Metalor,” said Koichiro (Frank) Tanaka, Group CEO of TANAKA. “Their partnership will create new synergies within TANAKA, further strengthening our shared commitment to sustainable and responsible precious metal refining for customers and industries worldwide.”About Gannon & Scott Gannon & Scott provides precious metal refining, thermal processing, and secure materials recovery services to businesses across North America. With operations in Cranston, RI, and Phoenix, AZ, the company serves sectors including electronics, plating, jewelry, aerospace, and certified destruction.About Metalor TechnologiesFounded in 1852, Metalor is a global leader in precious metals refining, advanced materials, and fine chemicals. Headquartered in Switzerland with operations in Europe, Asia, and the Americas, and more than 1,550 employees worldwide, Metalor is recognized for its refining excellence, high-quality products, and long-standing partnerships across banking, luxury goods, electronics, and chemical sectors. The company is part of TANAKA.About TANAKAFounded in 1885 and headquartered in Japan, TANAKA offers a broad range of advanced precious metal materials for industrial use, as well as assets and jewelry. As a global precious metals specialist, TANAKA’s group companies worldwide collaborate in procurement, R&D, manufacturing, sales, customer service, and recycling to deliver comprehensive products and services. The group has 5,591 employees, and its consolidated net sales for fiscal year 2024 totaled 846.9 billion yen (approximately 5.96 billion USD).Press inquiriesTANAKA PRECIOUS METAL GROUP Co., Ltd.https://www.tanaka.co.jp/support/req/other_contact_e/index.htmlPress release: http://www.acnnewswire.com/docs/files/251028.pdf Copyright 2025 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com
Olympus Introduces NBI+TXI(TM) Observation Mode to the EVIS X1(TM) Endoscopy System CV-1500 Video System Center
TOKYO, Oct 29, 2025 - (JCN Newswire via SeaPRwire.com) - Olympus Corporation (Olympus), a global MedTech company committed to making people’s lives healthier, safer and more fulfilling, today announced the launch of the NBI+TXI™ observation mode, which combines Narrow Band Imaging (NBI™ mode) and Texture and Color Enhancement Imaging (TXI™ mode) into a single view. Sales of the EVIS X1™ endoscopy system featuring the NBI+TXI mode will begin in Japan in November 2025, with launches in other regions to follow pending local regulatory approvals.The latest NBI mode, and the TXI observation mode, combined in the CV-1500.Since its initial launch in April 2020, the EVIS X1 endoscopy system has supported healthcare professionals with advanced imaging technologies including TXI mode, NBI mode and RDI™ mode (Red Dichromatic Imaging). These proprietary innovations have contributed to more precise observation and treatment of gastrointestinal and respiratory diseases, including cancer.The NBI+TXI mode further strengthens the EVIS X1 endoscopy system’s diagnostic capabilities by enhancing the brightness correction and contrast information of NBI mode. This enables clearer visualization in darker areas of the image and sharper definition of vascular and mucosal patterns, which can contribute to improved detection and diagnostic accuracy for lesions, including those associated with cancers.According to 2021 statistics from the Ministry of Health, Labour and Welfare1, colorectal cancer has the highest incidence rate among all types of cancer in Japan, with 154,585 cases, followed by lung cancer (124,531 cases), and stomach cancer (112,881 cases). These cancers also rank among the leading causes of cancer-related deaths, with lung cancer first (75,762 deaths), colorectal cancer second (53,131 deaths), and stomach cancer fourth (38,771 deaths).NBI mode, first introduced globally in 2006, brought a revolutionary change to endoscopic imaging by improving visibility of features that were previously difficult to detect, making the invisible visible. The CV-1500 incorporates the latest NBI mode, achieving improved brightness compared to the original NBI mode. TXI mode, introduced with the CV-1500, further improves the visibility of lesions through its image enhancement technology when used with conventional light observation. The combination of these two technologies in the CV-1500, the NBI+TXI observation mode is expected to further enhance and optimize the contrast information in NBI mode images, supporting more precise endoscopic examinations and treatments.NBI+TXI observation mode is expected to enhance the contrast information in NBI mode imaging.Supporting Better Mucosal VisibilityTXI mode supports better visibility of potential and extant lesions, such as areas of inflammation, flat or depressed lesions, or even tiny precursor lesions, by enhancing texture, brightness and color to define subtle tissue differences more clearly. With its advanced imaging technology, TXI mode has the potential to reinvent white light in endoscopy. By supporting better visibility of potential and extant lesions, TXI mode may contribute to higher detection rates and improve qualitative diagnosis.NBI mode is a powerful and proven optical technology creating strong contrast between vessels and surrounding mucosa that allows for a high-confidence optical diagnosis using specific blue and green wavelengths. NBI mode not only supports earlier detection of lesions but also provides a more detailed, higher-contrasted visualization that can improve qualitative diagnosis.“We know that early detection improves patient care and outcomes.” said Kurt Heine, Senior Vice President and General Manager for Gastroenterology, Olympus. “Olympus is committed to providing the advanced endoscopic imaging physicians need to clearly visualize the GI tract and provide timely diagnoses and treatment. We're excited to expand upon the innovations of our EVIS X1 endoscopy system with this combined imaging mode capability and continue elevating the standard of care."Physicians attending JDDW, scheduled for October 30–November 1, 2025 at the Kobe Convention Center will have the opportunity to see the combined NBI+TXI imaging mode firsthand.1 CANCER INCIDENCE OF JAPAN 2021About OlympusAt Olympus, we are committed to Our Purpose of making people’s lives healthier, safer and more fulfilling. As a global medical technology company, we partner with healthcare professionals to provide innovative solutions and services for early detection, diagnosis and minimally invasive treatment, aiming to improve patient outcomes by elevating the standard of care in targeted disease states. For more than 100 years, Olympus has pursued a goal of contributing to society by producing products designed with the purpose of delivering optimal outcomes for its customers around the world. For more information, visit https://www.olympus-global.com/ and follow our global LinkedIn and X accounts.Media contact:Mail: Global-Public_Relations@olympus.com.Olympus Corp [TYO: 7733] [ADR: OLYMY] [STU: OLY1] [FRA: OLYS] https://www.olympus-global.com Copyright 2025 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com
Northeast Asia Video Summit Spotlights Global Content Strategies, Streaming Innovation, and the Future of Media Monetization
TOKYO, Japan – October 30, 2025 - (ACN Newswire via SeaPRwire.com) - The Northeast Asia Video Summit 2025, hosted by the Asia Video Industry Association (AVIA), brought together leading media executives, content creators, and technology innovators to explore the future of video in Japan and Korea. Held in Tokyo, the summit showcased transformative strategies in global content production, streaming monetization, and cross-border collaboration.A central theme of the summit was the global ascent of Japanese and Korean content. In a compelling keynote, Katsuaki Setoguchi, Executive Officer at TBS Holdings and President and CEO of THE SEVEN Inc., emphasized that Japan’s ambition to go global is rooted not in profit, but in cultural promotion. “Storytelling is our foundation,” Setoguchi said, highlighting the success of Alice in Borderland and upcoming co-productions with U-Next. He outlined a formula for global success: strategic IP selection, elevated production budgets, and partnerships with platforms like Netflix and Amazon to reach a global audience. Setoguchi also stressed the importance of long-term regional collaboration, particularly in Southeast Asia, citing their strategic alliance with Vietnam TV.Yu Sasamoto, CEO of DAZN Japan and APAC Business Development, shared insights into Japan’s evolving sports streaming landscape. With partnerships like Docomo and Meta, DAZN is redefining how fans engage with live sports. Sasamoto revealed that DAZN is set to triple its subscriber base in Japan and is leveraging social media to convert engagement into subscriptions. Sasamoto also shared his ambitions to expand Japanese sports globally by building an ecosystem that blends content, technology, and partnerships to scale across Asia.Streaming monetization was another hot topic. Joshua Sunghyun Cho, CBO of TVING, detailed the platform’s innovative ad strategies, including impression-guaranteed products and interactive formats like “Watch Together.” Partnering with Moloco, TVING doubled its ad revenue from KBO baseball broadcasts and is now targeting contextual and shopping ads. “Streaming is no longer just premium branding—it’s performance-driven,” Cho said. Nick Chuah, Managing Director APAC at INVIDI, added that addressable advertising is poised to reshape Japan’s TV ad market, with data-driven campaigns delivering measurable ROI and unlocking new value for brands.Executives from Dentsu, FAST Corporation, and Integral Ad Science also echoed the need for collaboration, standardization, and advocacy to accelerate CTV adoption in Japan. With new smart TVs and platforms like TVer and ABEMA entering the programmatic space, the market is poised for rapid growth.The summit also addressed the future of anime as a global cultural force. Yuichiro Saito, CEO of Studio CHIZU, and Hideki Henry Goto, President of OKUTAGON LLC, discussed anime’s expanding international footprint. With over half of revenue now coming from global markets, speakers called for new business models, international co-productions, and talent development to sustain growth, with Saito advocating for creative integrity and global collaboration.In the closing keynote, executives from Warner Bros. Discovery, SKY Perfect JSAT, and A+E Global Media debated the future of pay TV and streaming economics in Japan. While acknowledging the slow decline of linear TV, they emphasized the enduring value of local partnerships and bundling strategies. Japan’s rich history and vibrant culture continue to produce compelling stories, presenting vast opportunities for international partnerships to bring this content to global audiences. The speakers agreed that creative distribution models and co-productions will be key to unlocking Japan’s full potential on the global stage.The Northeast Asia Video Summit is proudly sponsored by Gold Sponsors Moloco and Publica by IAS, and Silver Sponsors Encompass, INVIDI and TV5MONDE.Click here for a selection of photos from the Summit.About the Asia Video Industry AssociationThe Asia Video Industry Association (AVIA) is the trade association for the video industry and ecosystem in Asia Pacific. It serves to make the video industry stronger and healthier through promoting the common interests of its members. AVIA is the interlocutor for the industry with governments across the region, leads the fight against video piracy through its Coalition Against Piracy (CAP) and provides insight into the video industry through reports and conferences aimed to support a vibrant video industry.For media enquiries and additional background information, please contact:Charmaine KwanHead of Marketing and CommunicationsEmail: charmaine@avia.org | Website: www.avia.orgLinkedIn: www.linkedin.com/company/asiavideoia |X: @AsiaVideoIA Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
Eisai and Merck & Co., Inc., Rahway, NJ, USA Provide Update on Phase 3 LEAP012 Trial in Unresectable, Non-Metastatic Hepatocellular Carcinoma
TOKYO and RAHWAY, NJ, Oct. 29, 2025 - (JCN Newswire via SeaPRwire.com) - Eisai (Headquarters: Tokyo, CEO: Haruo Naito) and Merck & Co., Inc., Rahway, NJ, USA (known as MSD outside of the United States and Canada) today announced results from that Phase 3 LEAP-012 trial evaluating LENVIMA® (lenvatinib), the orally available multiple receptor tyrosine kinase inhibitor (TKI)discovered by Eisai, plus KEYTRUDA® (pembrolizumab), the anti-PD-1 therapy from Merck & Co.,Inc., Rahway, NJ, USA, in combination with transarterial chemoembolization (TACE) for the treatment of patients with unresectable, non-metastatic hepatocellular carcinoma (HCC).At a pre-specified interim analysis, LENVIMA plus KEYTRUDA in combination with TACE did not achieve statistical significance for overall survival (OS), one of the study’s primary endpoints, compared to TACE alone. The likelihood of reaching the protocol-specified threshold for statistical significance for OS at a future analysis was evaluated by Eisai and Merck & Co.,Inc., Rahway, NJ, USA and considered to be low. On this basis, the study will be closed, and the companies are informing investigators of this decision.The safety profile of the LENVIMA plus KEYTRUDA-based regimen was consistent with that observed in previously reported studies evaluating the combination and in earlier analyses of LEAP-012. Further analysis of the data is ongoing. Eisai and Merck & Co., Inc., Rahway, NJ, USA will work with investigators to share the results with the scientific community.As reported previously, LENVIMA plus KEYTRUDA in combination with TACE met the study’s other primary endpoint of progression-free survival (PFS) and demonstrated a statistically significant and clinically meaningful improvement compared to TACE alone. Data from this first interim analysis, which served as the final analysis for the endpoint of PFS, were presented at the European Society for Medical Oncology (ESMO) Congress 2024 and published in The Lancet. With additional follow-up at subsequent analyses, PFS remained consistent.“Although the progression-free survival results from this study are encouraging, unfortunately, the addition of KEYTRUDA plus LENVIMA to TACE did not show the overall survival benefit we hoped,” said Dr. Gregory Lubiniecki, Vice President, Global Clinical Development, MSD Research Laboratories. “We are grateful to the patients and investigators for their important contributions to this study, and our commitment is unwavering as we pursue new therapeutic options for people living with hepatocellular carcinoma, an aggressive and challenging-to-treat cancer.”“The overall survival findings from LEAP-012, along with the previously reported improvement in progression-free survival, provide important insights for treating unresectable, non-metastatic hepatocellular carcinoma,” said Dr. Corina Dutcus, Senior Vice President, Oncology Global Clinical Development Lead at Eisai. “For years, TACE has been a standard of care for these patients, yet many experience disease progression within twelve months. With LEAP-012, we sought to make a meaningful difference for this patient population. LENVIMA continues to play an important role as a monotherapy treatment option for patients with unresectable HCC, and as a company with a deep heritage in liver cancer research, Eisai remains committed to advancing the science.”In July 2025, LENVIMA plus KEYTRUDA in combination with TACE was approved in China to treat unresectable non-metastatic HCC. The LENVIMA plus KEYTRUDA combination is approved in the U.S., the European Union (EU), Japan and other countries for the treatment of advanced renal cell carcinoma (RCC) and certain types of advanced endometrial carcinoma. Results from the LEAP-012 trial do not affect the current approved indications for the LENVIMA plus KEYTRUDA combination, including the approval of LENVIMA plus KEYTRUDA in combination with TACE in China to treat unresectable non-metastatic HCC.LENVIMA monotherapy is approved for the treatment of patients with unresectable HCC in more than 80 countries and regions, including in the U.S., the EU, China and Japan.KEYTRUDA is approved as a monotherapy for the treatment of patients with HCC secondary to hepatitis B who have received prior systemic therapy other than a PD-1/PD-L1-containing regimen in the U.S. and as a monotherapy for the treatment of patients with HCC who have been previously treated with sorafenib or oxaliplatin-containing chemotherapy in China.For more details, please visit: https://www.eisai.com/news/2025/pdf/enews202576pdf.pdf Copyright 2025 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com
Mazda Presents World Premiere of Two Vision Models at Japan Mobility Show 2025
HIROSHIMA, Japan, October 29, 2025 - (JCN Newswire via SeaPRwire.com) - During the press conference at the Japan Mobility Show 2025(*1) today, Mazda Motor Corporation (Mazda) unveiled two vision models, the MAZDA VISION X-COUPE and the MAZDA VISION X-COMPACT (‘X’ pronounced as ‘cross’ ), both embodying the Company’s theme for this year's exhibition: “The Joy of Driving Fuels a Sustainable Tomorrow” for 2035.The MAZDA VISION X-COUPE is a crossover coupe that embodies the further evolution of ‘KODO-Soul of Motion’ design language. It is powered by a plug-in hybrid system integrating a two-rotor rotary turbo engine with a motor and battery. With a maximum output of 510 PS, the vehicle offers a driving range of 160 km in motor-only mode and up to 800 km when operating in combination with the engine. Furthermore, by combining carbon-neutral fuel derived from microalgae with Mazda’s proprietary CO2 capture technology, “Mazda Mobile Carbon Capture,” the vehicle contributes to reducing atmospheric CO2 the more it is driven.MAZDA VISION X-COUPEThe MAZDA VISION X-COMPACT is a model designed to deepen the bond between people and cars through the fusion of a human sensory digital model and empathetic AI. Acting like a close companion, it is capable of engaging in natural conversation and suggesting destinations, helping expand the driver’s world. This represents Mazda’s vision for the future of smart mobility, where vehicles and people form an emotional connection, much like a friend.MAZDA VISION X-COMPACTFurthermore, the All-New MAZDA CX-5 (European specification) (*2) , is on display to the general public for the first time ever. Featuring a spacious interior, refined KODO design, and enhanced Jinba-ittai (oneness between driver and car) driving dynamics, this model represents the evolution of a best-selling vehicle that has sold over 4.5 million units (*3) across more than 100 countries and regions. Designed with the new electronic platform “MAZDA E/E ARCHITECTURE+”, this latest model aims to offer an evolved driving experience.Masahiro Moro, Representative Director, President and CEO of Mazda, stated: “The phrase, ‘The joy of driving fuels a sustainable tomorrow,’ expresses not only Mazda’s fundamental spirit, but also the core of its future challenges. Under the shared global mission of achieving carbon neutrality, Mazda believes that the joy of driving can be a force for positive change for society and the planet. We remain committed to fulfilling the desire of those who love cars and wish to continue driving forever.”Mazda will continue to evolve the ‘Joy of Driving’ based on the value of ‘Radically Human,’ and will aim to deliver the ‘Joy of Living’ by creating exciting mobility experiences in our customers' daily lives.Overview of the MAZDA VISION X-COUPE and MAZDA VISION X-COMPACTModelMAZDA VISION X-COUPEMAZDA VISION X-COMPACTOverall Length5,050 mm3,825 mmOverall Width1,995 mm1,795 mmOverall Height1,480 mm1,470 mmWheelbase3,080 mm2,515 mm*1 Hosted by the Japan Automobile Manufacturers Association, Inc.Press Day: Wednesday, October 29, 8:00-18:00, and Thursday, October 30, 8:00-13:00.Public Day: starting Friday, October 31 until Sunday, November 9.*2 For the new MAZDA CX-5, please see the news release at the following URL.https://newsroom.mazda.com/en/publicity/release/2025/202507/250710a.html*3 Mazda's best-selling model in its current lineup from 2018 to 2024 Copyright 2025 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com
Mazda Rolls Out New Version of Brand Symbol from Japan Mobility Show 2025
HIROSHIMA, Japan, October 29, 2025 - (JCN Newswire via SeaPRwire.com) - Mazda Motor Corporation (Mazda) announced today that it will gradually roll out a new version of its brand symbol, embodying its unwavering belief and enduring commitment to shaping the future. This brand symbol will also be featured at the Mazda booth at the Japan Mobility Show 2025, a place to showcase the future of the Mazda brand to the world, delivering Mazda's new brand expression to visitors. Mazda booth at Japan Mobility Show 2025 featuring the new version of the brand symbolThe new version of Mazda’s brand symbol inherits the spirit of its symbol introduced in June 1997, representing the letter 'M' with the evocation of soaring wings. This embodies the Company’s commitment to continuous self-reform and dynamic, unceasing growth. It demonstrates the evolution of the brand toward the next generation.The sleek and bold form enhances visibility, particularly in digital environments, resulting in a more refined design. The new version of the wordmark, launched alongside it, adopts a modern style. The new version of the brand symbol and wordmark are now being adopted on the Mazda corporate website starting today.New version of the brand symbol in the digital areaThe new version of the brand symbol and the current brand symbol will be applied optimally according to location and media characteristics to enhance global brand recognition.Mazda will continue to pursue the "Joy of Driving" under its core value of “Radically Human,” and aim to deliver the "Joy of Living" by creating moving mobility experiences in the daily lives of its customers.*Definition of Each Mark Reference- Mazda corporate website featuring the new version of the brand mark:https://www.mazda.com/en/- Mazda brand mark history page:https://www.mazda.com/en/about/history/mark- Japan Mobility Show 2025 Mazda Exhibit Release:https://newsroom.mazda.com/en/publicity/release/2025/202510/251014a.html Copyright 2025 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com
NEC and the Cambodian Mine Action Center Successfully Predict Landmine-Contaminated Areas in Cambodia Using AI
TOKYO, Japan, October 29, 2025 - (JCN Newswire via SeaPRwire.com) - NEC Corporation (NEC; TSE: 6701) and the Cambodian Mine Action Center (CMAC, *1), the national institution responsible for landmine clearance activities in Cambodia, with assistance from JICA (*2), conducted a proof-of-concept using AI to predict landmine-contaminated areas. This initiative aims to contribute to rapid and efficient clearance operations to eliminate landmine casualties. The proof-of-concept achieved highly accurate predictions, with a match rate exceeding 90% against actual landmine locations.This initiative also received recognition through "The GICHD Innovation Award 2025," hosted by the Geneva International Centre for Humanitarian Demining (GICHD, *3), which honors outstanding technologies contributing to progress in demining activities. The award was presented at a ceremony held in Luxembourg on Tuesday, October 28. Removing landmines in an area Award Ceremonypredicted by AI in Cambodia ©GICHD/PANCAKE! PhotographieThe use of landmines remains a humanitarian issue worldwide, particularly hindering community and economic development for extended periods in post-conflict nations. It is estimated that approximately 100 million people face the threat of landmines, with one person losing their life to a landmine every 90 minutes (*4).In Cambodia, civil war spanning the 1970s and 1990s led to the widespread burial of landmines across the country. Despite years of dedicated clearance efforts, remnant landmines persist in some areas today. These landmines prevent the use of land for farming and residential purposes, posing serious obstacles to recovery and development.The Cambodian government, based on the Ottawa Treaty (Convention on the Prohibition of the Use, Stockpiling, Production and Transfer of Anti-Personnel Mines and on Their Destruction) signed in 1997, has set a target of completing landmine clearance within Cambodia by 2030. To achieve this, it is expected that advanced technologies such as AI will be utilized to reduce survey time.This demonstration targeted approximately 1 million square meters of Cambodia's landmine fields. NEC's AI analyzed information based on data that included CMAC's records of detected landmine locations, resident-provided information, and open data such as river/mountainous terrain locations and factory/critical building sites. It then accurately predicted areas with a high probability of containing buried landmines.Traditionally, identifying potential landmine-infested areas required extensive, unorganized data and significant manpower over long periods. By leveraging AI, this process can now be performed quickly with fewer personnel, demonstrating the potential to support swift and efficient landmine clearance.Going forward, NEC will continue striving to further improve AI's accuracy. Working with CMAC, with assistance from JICA, and strengthening collaboration with the Japanese government, NEC will accelerate efforts toward achieving Cambodia's goal of completing landmine clearance by 2030. Furthermore, NEC aims to contribute to other landmine-affected countries using this technology in the future.(*1) Cambodian Mine Action Center (CMAC)Location: Phnom Penh, Cambodia; Director: Heng Rathana(*2) Japan International Cooperation Agency(*3) Geneva International Center for Humanitarian Demining (GICHD)Location: Geneva, Switzerland; Director: Stefano Toscan(*4) Source: the-monitor.org/reports/landmine-monitorLandmine Monitor 2024 Full PaperAbout NEC CorporationNEC Corporation has established itself as a leader in the integration of IT and network technologies while promoting the brand statement of “Orchestrating a brighter world.” NEC enables businesses and communities to adapt to rapid changes taking place in both society and the market as it provides for the social values of safety, security, fairness and efficiency to promote a more sustainable world where everyone has the chance to reach their full potential. For more information, visit NEC at https://www.nec.com. Copyright 2025 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com


















